Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 40, Issue 7, 2005, Pages 1022-1027

  Simonelli, Cecilia ^a   Tedeschi, Rosamaria ^a   Gloghini, Annunziata ^a   Bortolin, Maria Teresa ^a   Spina, Michele ^a   Bidoli, Ettore ^a   Cinelli, Roberta ^a   De Paoli, Paolo ^a   Carbone, Antonino ^a   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DAUNORUBICIN; DIDANOSINE; INDINAVIR; LAMIVUDINE; PREDNISONE; STAVUDINE; VINCRISTINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; VIRAL LOAD; VIRAL PROTEINS; VIREMIA;

EID: 20144376361     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428615     Document Type: Article

References (36)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88:645-56.
3. Carbone A, Gaidano G. HHV-8 positive body cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97:515-22.
4. Morassut S, Vaccher E, Balestreri L, al. HIV-associated HHV-8 positive primary lymphomatous effusions: radiological findings in six patients. Radiology 1997; 205:459-63.
5. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 1996; 94:533-43.
6. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99:2331-6.
7. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95:1406-12.
8. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal malignancies. Leukemia 1996; 10:1358-62.
9. Engels EA, Pittaluga S, Whitby D, et al. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 2003; 16:424-9.
10. Boivin G, Gaudreau A, Routy IP. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS 2000; 14:1907-10.
11. Campbell TB, Fitzpatrick L, MaWhinney S, Zhang X, Schooley RT. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection. J Acquir Immune Defic Syndr 1999; 22:333-40.
12. Campbell TB, Borok M, Gwanzura L. HHV-8 peripheral blood viral load and the titer of antibodies against HHV-8. N Engl J Med 1999; 341:1241-2.
13. Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 2000; 38:1404-8.
14. Wit FW, Sol CJ, Renwick N, et al. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 1998; 12:218-9.
15. Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner I. Viral load human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 2001; 39:4269-73.
16. de Jong RB, Kluin PM, Rosati S, van Haelst PL, Sprenger HG, van Spronsen DJ. Sustained high levels of serum HHV-8 DNA years before multicentric Castleman's disease despite full suppression of HIV with highly active antiretroviral therapy. AIDS 2003; 17:1407-18.
17. Grandadam M, Dupin N, Calvez V, et al. Exacerbation of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis 1997; 175:1198-201.
18. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 2000; 96:2069-73.
19. Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood 2003; 102:2786-8.
20. Marrache F, Larroche C, Mémain N, et al. Prolonged remission of HIV-associated multicentric Castleman's disease with an anti-CD20 monoclonal antibody as primary therapy. AIDS 2003; 17:1409-10.
21. Corbellino M, Bestetti G, Scalamogna C, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001; 98:3473-5.
22. Boulanger E, Daniel MT, Agbalika F, Oksenhendler E. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol 2003; 73:143-8.
23. Spina M, Gaidano G, Carbone A, Capello D, Tirelli U. Highly active antiretroviral therapy in human herpesvirus-8-related body-cavity-based lymphoma. AIDS 1998; 12:955-6.
24. Naylor B. Pleural, peritoneal, and pericardial fluids. In: Bibbo M, ed. Comprehensive cytopathology. Philadelphia: WB Saunders, 1991: 541-60.
25. Carbone A, Cilia AM, Gloghini A, et al. Establishment of HHV-8 positive and HHV-8 negative lymphoma cell lines from primary lymphomatous effusions. Br J Haematol 1998; 102:1081-9.
26. Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002; 100:1984-8.
27. Pratesi C, Bortolin MT, D'Andrea M, et al. Quantitative plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients. J Clin Virol 2003; 28:155-64.
28. Pan L, Milligan L, Michaeli I, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn 2001; 3:32-8.
29. Carbone A, Cilia AM, Gloghini A, et al. Establishment of HHV-8 positive and HHV-8 negative lymphoma cell lines from primary lymphomatous effusions. Int J Cancer 1997; 73:562-9.
30. Gaidano G, Pastore C, Gloghini A, et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 1996; 10:941-9.
31. Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 2003; 21:3948-54.
32. Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 2003; 9:554-61.
33. Davis MA, Sturzl MA, Blasig C, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997; 89:1868-74.
34. Krigel RL, Friedman-Kien A. Kaposi's sarcoma in AIDS: diagnosis and treatment. In: De Vita V, Hellman S, Rosenberg SA, eds. AIDS - etiology, diagnosis, treatment, and prevention. 2nd ed. Philadelphia: JB Lippincott, 1988:245-61.
35. Oksenhendler E, Clauvel JP, Jouveshomme S, Davi F, Mansour G. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol 1998; 57:266.
36. Hocqueloux L, Agbalika F, Oksenhendler E, Molina JM. Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. AIDS 2001; 15:280-2.